117 related articles for article (PubMed ID: 2157176)
21. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
22. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
23. Induction of a variety of preneoplasias and tumours in the mammary glands of transgenic rats.
Davies BR; Warren JR; Schmidt G; Rudland PS
Biochem Soc Symp; 1998; 63():167-84. PubMed ID: 9513721
[TBL] [Abstract][Full Text] [Related]
24. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
25. Role of chromatin structure in transcriptional regulation of MMTV LTR hormone-dependent promoter.
Richard-Foy H; Adom J; Carr K; Gouilleux F; Marsaud V; Redeuilh G; Sabbah M; Sola B
Rev Esp Fisiol; 1990 Mar; 46(1):31-7. PubMed ID: 2168572
[TBL] [Abstract][Full Text] [Related]
26. Immortalization and transformation of human fibroblasts by regulated expression of polyoma virus T antigens.
Strauss M; Hering S; Lubbe L; Griffin BE
Oncogene; 1990 Aug; 5(8):1223-9. PubMed ID: 1697410
[TBL] [Abstract][Full Text] [Related]
27. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
Mulholland NM; Soeth E; Smith CL
Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
Lo J; Hurta RA
Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
[TBL] [Abstract][Full Text] [Related]
30. The regulation of expression of mouse mammary tumor virus DNA by steroid hormones and growth factors.
Cato AC; Weinmann J; Mink S; Ponta H; Henderson D; Sonnenberg A
J Steroid Biochem; 1989; 34(1-6):139-43. PubMed ID: 2560510
[TBL] [Abstract][Full Text] [Related]
31. Mouse mammary tumor proviral gene expression in cells of the B lineage.
Corley RB; Lund FE; Randall TD; King LB; Doerre S; Woodland DL
Semin Immunol; 1992 Oct; 4(5):287-96. PubMed ID: 1336679
[TBL] [Abstract][Full Text] [Related]
32. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
[TBL] [Abstract][Full Text] [Related]
33. Prolactin, epidermal growth factor or transforming growth factor-alpha activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat.
Haraguchi S; Good RA; Engelman RW; Greene S; Day NK
Mol Cell Endocrinol; 1997 May; 129(2):145-55. PubMed ID: 9202398
[TBL] [Abstract][Full Text] [Related]
34. The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements.
Mink S; Ponta H; Cato AC
Nucleic Acids Res; 1990 Apr; 18(8):2017-24. PubMed ID: 2159634
[TBL] [Abstract][Full Text] [Related]
35. Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene.
Ciardiello F; Kim N; Hynes N; Jaggi R; Redmond S; Liscia DS; Sanfilippo B; Merlo G; Callahan R; Kidwell WR
Mol Endocrinol; 1988 Dec; 2(12):1202-16. PubMed ID: 3063955
[TBL] [Abstract][Full Text] [Related]
36. Mouse mammary tumour virus: a proviral gene contributes to the understanding of eukaryotic gene expression and mammary tumorigenesis.
Ponta H; Günzburg WH; Salmons B; Groner B; Herrlich P
J Gen Virol; 1985 May; 66 ( Pt 5)():931-43. PubMed ID: 2987402
[No Abstract] [Full Text] [Related]
37. Eukaryotic gene regulation studies with mouse mammary tumor virus in tissue culture cells.
Parks WP; Young HA; Scolnick EM
Natl Cancer Inst Monogr; 1978 May; (48):215-8. PubMed ID: 219353
[TBL] [Abstract][Full Text] [Related]
38. Increased concentration of an indigenous proviral mouse mammary tumor virus long terminal repeat-containing transcript is associated with neoplastic transformation of mammary epithelium in C3H/Sm mice.
Graham DE; Medina D; Smith GH
J Virol; 1984 Mar; 49(3):819-27. PubMed ID: 6321767
[TBL] [Abstract][Full Text] [Related]
39. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.
Matsui Y; Halter SA; Holt JT; Hogan BL; Coffey RJ
Cell; 1990 Jun; 61(6):1147-55. PubMed ID: 2161707
[TBL] [Abstract][Full Text] [Related]
40. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.
Jaggi R; Salmons B; Muellener D; Groner B
EMBO J; 1986 Oct; 5(10):2609-16. PubMed ID: 3023051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
